13.39
Precedente Chiudi:
$12.18
Aprire:
$13.74
Volume 24 ore:
19,473
Relative Volume:
0.27
Capitalizzazione di mercato:
$347.53M
Reddito:
$26.00M
Utile/perdita netta:
$-219.71M
Rapporto P/E:
-0.2689
EPS:
-49.8
Flusso di cassa netto:
$-51.37M
1 W Prestazione:
+0.90%
1M Prestazione:
+36.22%
6M Prestazione:
-31.05%
1 anno Prestazione:
-21.28%
Cartesian Therapeutics Inc Stock (RNAC) Company Profile
Nome
Cartesian Therapeutics Inc
Settore
Industria
Telefono
301-348-8698
Indirizzo
7495 NEW HORIZON WAY, FREDERICK
Confronta RNAC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
RNAC
Cartesian Therapeutics Inc
|
13.39 | 316.12M | 26.00M | -219.71M | -51.37M | -49.80 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-09 | Iniziato | Wedbush | Outperform |
2024-12-19 | Iniziato | BTIG Research | Buy |
2024-08-06 | Iniziato | TD Cowen | Buy |
2024-07-02 | Downgrade | Oppenheimer | Outperform → Perform |
2024-06-04 | Iniziato | Oppenheimer | Outperform |
2024-05-24 | Iniziato | Mizuho | Buy |
2024-04-23 | Reiterato | H.C. Wainwright | Buy |
2024-04-23 | Iniziato | Leerink Partners | Outperform |
2023-08-18 | Downgrade | SVB Securities | Outperform → Market Perform |
2022-06-14 | Reiterato | Needham | Buy |
2022-06-06 | Iniziato | SVB Leerink | Outperform |
2021-06-15 | Iniziato | BTIG Research | Buy |
2021-01-26 | Aggiornamento | Mizuho | Neutral → Buy |
2020-10-01 | Downgrade | Mizuho | Buy → Neutral |
2020-10-01 | Downgrade | William Blair | Outperform → Mkt Perform |
2020-06-12 | Downgrade | Stifel | Buy → Hold |
2020-04-28 | Iniziato | H.C. Wainwright | Buy |
2020-01-29 | Iniziato | Cantor Fitzgerald | Overweight |
2020-01-21 | Iniziato | William Blair | Outperform |
2018-06-27 | Iniziato | Janney | Buy |
2017-03-30 | Reiterato | UBS | Buy |
Mostra tutto
Cartesian Therapeutics Inc Borsa (RNAC) Ultime notizie
Cartesian Therapeutics Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - Autocar Professional
Is Cartesian Therapeutics Inc. a good long term investmentSkyrocketing investment returns - jammulinksnews.com
What drives Cartesian Therapeutics Inc. stock priceRapid growth trajectories - jammulinksnews.com
What analysts say about Cartesian Therapeutics Inc. stockFree Stock Market Forecast Reports - jammulinksnews.com
What makes Cartesian Therapeutics Inc. stock price move sharplyFree Stock Market Swing Trading Strategies - Newser
Multiple Myeloma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis CASI Pharmaceuticals, Carsgen Therapeutics, Cartesian Therapeutics - MenaFN
Why Cartesian Therapeutics Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser
How Cartesian Therapeutics Inc. stock performs during market volatilityShort Squeeze Radar - Newser
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives $40.00 Average Price Target from Analysts - Defense World
What is Wedbush’s Estimate for RNAC Q2 Earnings? - Defense World
Cartesian Therapeutics Advances mRNA CAR T-cell Therapy for Myasthenia Gravis - TipRanks
Wedbush Initiates Coverage on Cartesian Therapeutics (NASDAQ:RNAC) - Defense World
CartesianAutoimmune Cell Therapy Excites, But Reality Bites (NASDAQ:RNAC) - Seeking Alpha
Wedbush initiates coverage on Cartesian Therapeutics stock with Outperform rating - Investing.com Canada
Cartesian stock up as Wedbush becomes bullish (RNAC:NASDAQ) - Seeking Alpha
Cartesian Therapeutics' 15min chart sees KDJ Golden Cross, bullish Marubozu formation. - AInvest
AbbVie Makes Big Autoimmune CAR-T Play With Capstan Acquisition - insights.citeline.com
What caused RNAC's earnings to miss forecasts in Q4 2023? - AInvest
Rhumbline Advisers Grows Stock Position in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World
We're Not Very Worried About Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Rate - Yahoo Finance
Myasthenia Gravis Market to Expand Significantly by 2034, States DelveInsight Report | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen Research & Development, LLC - The Globe and Mail
IBM Introduces Industry-First Software to Unify Agentic Governance and Security - The Globe and Mail
Cartesian Therapeutics holds annual stockholders meeting By Investing.com - Investing.com South Africa
Cartesian Therapeutics holds annual stockholders meeting - Investing.com
Cartesian Therapeutics Holds Annual Stockholders Meeting - TipRanks
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Shares Acquired by Bank of America Corp DE - Defense World
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Two Sigma Investments LP Reduces Holdings in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World
Equities Analysts Offer Predictions for RNAC FY2026 Earnings - Defense World
Nuveen Asset Management LLC Buys 47,889 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World
Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewswire
Cartesian Therapeutics Announces New Employment Inducement Grants | RNAC Stock News - GuruFocus
Cartesian Therapeutics (RNAC) Issues Inducement Stock Options to New Employees | RNAC Stock News - GuruFocus
Cartesian Therapeutics Awards 26,350 Stock Options to Key New Hires in Autoimmune Disease Research - Stock Titan
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Cartesian Therapeutics Inc Azioni (RNAC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):